A novel endothelial-related prognostic index by integrating single-cell and bulk RNA sequencing data for patients with kidney renal clear cell carcinoma

DX Li, QX Yu, CX Zeng, LX Ye, YQ Guo, JF Liu… - Frontiers in …, 2023 - frontiersin.org
Background: Endothelial cells in the tumor microenvironment play an important role in the
development of kidney renal clear cell carcinoma (KIRC). We wanted to further identify the …

Protein disulfide-isomerase A3 is a robust prognostic biomarker for cancers and predicts the immunotherapy response effectively

Z Tu, Q Ouyang, X Long, L Wu, J Li, X Zhu… - Frontiers in …, 2022 - frontiersin.org
Background Protein disulfide isomerase A3 (PDIA3) is a member of the protein disulfide
isomerase (PDI) family that participates in protein folding through its protein disulfide …

The use of single-cell multi-omics in immuno-oncology

A Ma, G Xin, Q Ma - Nature Communications, 2022 - nature.com
Single-cell multi-omics (scMulti-omics) has brought transformative insights into immuno-
oncology, demonstrating success in describing novel immune subsets and defining …

[HTML][HTML] Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: a comprehensive analysis

U Mehraj, S Aisha, S Sofi, MA Mir - Advances in Cancer Biology-Metastasis, 2022 - Elsevier
Background Baculoviral inhibitor of apoptosis repeat-containing 5 or BIRC5, member of the
inhibitor of apoptosis (IAP), is a multitasking protein and among the top 100 deregulated …

Single-cell analysis of the pan-cancer immune microenvironment and scTIME portal

F Hong, Q Meng, W Zhang, R Zheng, X Li… - Cancer Immunology …, 2021 - AACR
Single-cell sequencing opens a new era for the investigation of tumor immune
microenvironments (TIME). However, at single-cell resolution, a pan-cancer analysis that …

Discovery of targets for immune–metabolic antitumor drugs identifies estrogen-related receptor alpha

A Sahu, X Wang, P Munson, JPG Klomp, X Wang… - Cancer discovery, 2023 - AACR
Drugs that kill tumors through multiple mechanisms have the potential for broad clinical
benefits. Here, we first developed an in silico multiomics approach (BipotentR) to find cancer …

ICBatlas: a comprehensive resource for depicting immune checkpoint blockade therapy characteristics from transcriptome profiles

M Yang, YR Miao, GY Xie, M Luo, H Hu, HF Kwok… - Cancer Immunology …, 2022 - AACR
Immune checkpoint blockade (ICB) therapy provides remarkable clinical benefits for multiple
cancer types. Much work is currently being conducted to investigate the mechanisms of ICB …

A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer

J Li, C Yang, Y Zheng - Scientific Reports, 2023 - nature.com
Disulfidptosis is a newly-identified non-programmed cell death mode with tight associations
with glucose metabolism. Elevated glycolysis is an important metabolic feature of tumor …

A novel necroptosis-related gene signature in skin cutaneous melanoma prognosis and tumor microenvironment

B Song, P Wu, Z Liang, J Wang, Y Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Necroptosis has been identified recently as a newly recognized programmed
cell death that has an impact on tumor progression and prognosis, although the necroptosis …

SPEED: single-cell pan-species atlas in the light of ecology and evolution for development and diseases

Y Chen, X Zhang, X Peng, Y Jin, P Ding… - Nucleic acids …, 2023 - academic.oup.com
It is a challenge to efficiently integrate and present the tremendous amounts of single-cell
data generated from multiple tissues of various species. Here, we create a new database …